View Sub-Topics

Featured

Events

View all

All Research

The FDA Nixes a Pathbreaking Drug for MS

Christopher DeMuth & Christopher DeMuth Jr.

Under the brand name Lemtrada (a product of Sanofi and its U.S. subsidiary Genzyme), the drug has been approved in recent months for treating MS in ...

Continue Reading

Re-Imagining the Doctor

Ronald W. Dworkin

The physician has long held a place of high regard in the American imagination. In our most idealized picture, the doctor is a well-trained, beneficen...

View PDF

Why The AMA's Obesity Ruling Is Bad Medicine

Hank Cardello

The American Medical Association's announcement this week that it regards obesity as a disease is terrible news for food companies, public health advo...

Continue Reading